市场再度上演因“预期定价”引发的剧烈波动。8月7日，礼来在财报中公布了二季度超预期业绩并上调全年指引，但同一天披露的小分子GLP-1受体激动剂orforglipron 的三期数据：36mg高剂量组72周减重11.5%（安慰剂校正后），不及司美格鲁肽2.4mg剂量组的15.1%。消息公布后礼来股价大幅回落，跌幅一度超过14%，市值蒸发约1000亿美元。数据显示，orforglipron 36mg组...
Source Link市场再度上演因“预期定价”引发的剧烈波动。8月7日，礼来在财报中公布了二季度超预期业绩并上调全年指引，但同一天披露的小分子GLP-1受体激动剂orforglipron 的三期数据：36mg高剂量组72周减重11.5%（安慰剂校正后），不及司美格鲁肽2.4mg剂量组的15.1%。消息公布后礼来股价大幅回落，跌幅一度超过14%，市值蒸发约1000亿美元。数据显示，orforglipron 36mg组...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.